Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2005 1
2006 1
2007 1
2010 3
2011 6
2012 1
2013 5
2014 2
2015 3
2016 2
2017 2
2018 5
2019 2
2020 4
2021 3
2022 6
2023 3
2024 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Peripheral blood immunophenotypic diversity in patients with rheumatoid arthritis and its impact on therapeutic responsiveness.
Kubo S, Miyazaki Y, Nishino T, Fujita Y, Kono M, Kawashima T, Ishigaki K, Kusaka K, Tanaka H, Ueno M, Satoh-Kanda Y, Inoue Y, Todoroki Y, Miyagawa I, Hanami K, Nakayamada S, Tanaka Y. Kubo S, et al. Among authors: hanami k. Ann Rheum Dis. 2024 Oct 4:ard-2024-226228. doi: 10.1136/ard-2024-226228. Online ahead of print. Ann Rheum Dis. 2024. PMID: 39366723
Efficacy, safety, and optimal intervention of belimumab for proliferative lupus nephritis patients in real-world settings: LOOPS registry.
Sakai H, Miyazaki Y, Nakayamada S, Kubo S, Hanami K, Fukuyo S, Yamaguchi A, Miyagawa I, Ueno M, Tanaka H, Todoroki Y, Ohkubo N, Funada M, Matsunaga S, Tanaka Y. Sakai H, et al. Among authors: hanami k. Rheumatology (Oxford). 2024 Sep 17:keae495. doi: 10.1093/rheumatology/keae495. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 39288317
Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a multicenter prospective observational study.
Sonomoto K, Nakayamada S, Fujino Y, Miyata H, Kubo S, Fujita Y, Inoue Y, Matsunaga S, Iwata S, Hanami K, Todoroki Y, Yoshinari-Korekoda H, Kawabe A, Yamaguchi A, Ueno M, Satoh-Kanda Y, Kanda R, Funada M, Ohkubo N, Kusaka K, Kosaka S, Nagayasu A, Fukuyo S, Nawata M, Miyazaki Y, Tokunaga M, Tanaka K, Okada Y, Tanaka Y. Sonomoto K, et al. Among authors: hanami k. Rheumatology (Oxford). 2024 Aug 1;63(8):2239-2248. doi: 10.1093/rheumatology/kead579. Rheumatology (Oxford). 2024. PMID: 37934120
Generation-Dependent Retention Rates and Reasons for Discontinuation of Molecular Targeted Therapies in Patients with Rheumatoid Arthritis: From FIRST Registry.
Kubo S, Miyazaki Y, Todoroki Y, Nagayasu A, Kanda R, Aritomi T, Matsunaga S, Ueno M, Miyagawa I, Sonomoto K, Hanami K, Nakayamada S, Tanaka Y. Kubo S, et al. Among authors: hanami k. Rheumatol Ther. 2023 Dec;10(6):1705-1723. doi: 10.1007/s40744-023-00603-8. Epub 2023 Oct 19. Rheumatol Ther. 2023. PMID: 37856034 Free PMC article.
50 results